secwatch.observer — SEC 8-K summary
======================================

Issuer:     INNOVATE Corp. (VATE)
CIK:        0001006837
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0001006837-24-000121
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INNOVATE Q2 net income $14.1M vs loss $10.5M YoY; revenue $313M (-15%), adj. EBITDA $26.7M
--------------------------------------------------------------------------------

- Revenue $313.1M (-15.1% YoY); net income $14.1M vs loss $10.5M; diluted EPS $0.10 vs ($0.13).
- Infrastructure: DBM Global revenue $305.2M (-15.8%) but net income $21.0M (vs $7.0M); adj. EBITDA $32.5M; gross margin expanded 650 bps to 20.2%.
- Life Sciences: R2 Glacial system record North America sales, 200% increase YoY; MediBeacon continues FDA kidney monitoring review.
- Spectrum: Broadcasting revenue $6.2M (+8.8%), adj. EBITDA $1.5M (vs $0.8M); launched third network Defy.
- Board approved 1-for-10 reverse stock split, effective August 9, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006837/000100683724000121/0001006837-24-000121-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006837/000100683724000121/hchc-20240807.htm
  HTML page:      https://secwatch.observer/filing/0001006837-24-000121

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer